Salem Investment Counselors Inc Cytosorbents Corp Transaction History

Salem Investment Counselors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$8.23 - $11.48 $82,300 - $114,800	-10,000 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$7.65 - $8.98 $76,500 - $89,800	10,000 New	10,000 $80,000
Q3 2019 Nov 13, 2019	SELL	$4.33 - $7.63 $56,290 - $99,190	-13,000 Closed	0 $0
Q3 2017 Nov 16, 2017	BUY	$4.5 - $6.2 $58,500 - $80,600	13,000	13,000 $79,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $44M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Salem Investment Counselors Inc with notifications on news.